Enhancing PR&MA decision making by combining cutting edge tools with proven field expertise to harness complexity in healthcare
'World class work delivered within very tight timelines' –
Vice President Europe Commercial Operations,
global specialty pharma company
Access to good public healthcare at sustainable prices is crucial to patients, providers and payors alike.
Akceso Advisors is your partner to maximise market access for your products, whether you are launching an innovative medicine, a generic drug or managing the lifecycle of a therapy. We have a proven track record of improving patient health through understanding and clearly articulating provider and payor needs. We create the right strategy to deliver rationally-priced medicines and devices. We have a wealth of experience in solving product access challenges across therapeutic areas in over 60 countries.
Akceso is a specialist pricing, reimbursement & market access consultancy. Headquartered in Basel, Switzerland, Akceso is directly represented through a worldwide network of advisors.
'The market assessment project provided very good, value-adding outcomes delivered on time within very tight timelines. Akceso looked at an unclear situation, analysed and framed it and drew conclusions and practical recommendations. Akceso also developed very practical tools beyond our original expectations, to support our own follow-up activities' –
Director Market Access & Commercial Effectiveness,
Novo Nordisk International
WORLD P&R NEWS HIGHLIGHTS
Akceso produces a monthly newsletter covering recent developments in Pricing, Reimbursement & Market Access. To subscribe, send a request to email@example.com
AKCESO RECENT NEWS
August 2017: Akceso publishes on Biosimilars
Akceso has a feature article in Business Development and Licensing Journal See the contents here
(for daily news please go to Akceso's Twitter Page)
December 2017 - Measuring the Return from Pharmaceutical Innovation 2017
A new study from Deloitte shows the continuing challenge in securing ROI from R&D
|phone:||+41 61 225 4393|
|Akceso Advisors AG